Home » Newsletters » BioWorld Science

BioWorld Science

July 13, 2009

View Archived Issues

Novel DNA repair inhibitors discovered by CSIC and CNIO for cancer treatment

Biovitrum claims leptin receptor antagonists

Somatostatin agonists reported by Biostatin for the treatment of cancer, inflammation and pain

Solvay has launched Creon in the U.S.

Novel PDE4 inhibitor K-34 shows effectiveness in chronic dermatitis in vivo

Novel monoclonal antibody against CD123 shows clinical potential in acute myeloid leukemia

Foresight presents preclinical FST-100 data from adenoviral conjunctivitis model

NexMed and Novartis terminate licensing agreement for NM-100060 for onychomycosis

FDA accepts for review NDA for Amylin, Lilly and Alkermes' exenatide in type 2 diabetes

Genfit presents update on phase II clinical trials of GFT-505

NanoBio completes USD 22 million series B financing round

WraSer to market SALVAT's Cetraxal for acute otitis externa in the U.S.

Genmab completes enrollment in pivotal study of Arzerra in CLL

Schering-Plough receives marketing approval in Japan for Remeron/Reflex in MDD

Schering-Plough receives marketing approval in Japan for Asmanex for bronchial asthma

Barusiban and atosiban compared in women undergoing controlled ovarian stimulation

ENGAGE, ENSURE trials show efficacy of fertility hormone corifollitropin alfa

Hsp90-targeted therapy potentially useful in triple-negative breast cancer

PDK-1 inhibitor OSU-03012 shows potential in benign and malignant schwanommas

Allon reports phase II davunetide intranasal results in schizophrenia

Amarin receives SPA agreement from FDA for phase III AMR-101 trial

Dharma reports results for drug delivery system with lidocaine and epinephrine

Yondelis approved in the Philippines for ovarian cancer and soft tissue sarcoma

Alimta approved in Europe as maintenance therapy for non-squamous NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...